Literature DB >> 24657109

Screening and treatment of osteoporosis after hip fracture: comparison of sex and race.

Maria Antonelli1, Douglas Einstadter2, Marina Magrey2.   

Abstract

Most patients with osteoporosis (OP) are untreated and remain so even after hip fracture. Outcomes after osteoporotic hip fractures are worse among men and non-Caucasians compared with Caucasian women. We hypothesized that screening and treatment of OP after hip fracture remains low in men and non-Caucasian women. We identified all patients aged 65 yr or older with a primary diagnosis of hip fracture (ICD9-DM code 820.xx) discharged from an urban public hospital between January 1, 2000 and December 31, 2010. Patients with active malignancy (1 yr before or after the fracture) and Paget's disease were excluded. Also, patients were excluded if they had less than 2 encounters for post-event care at the hospital. Patient charts were reviewed to obtain information on demographics, post-fracture OP screening status (dual-energy X-ray absorptiometry [DXA] ordered or resulted), OP treatment status (prescription for oral bisphosphonates, raloxifene, zoledronic acid, calcitonin, or teriparatide), and referral to rheumatology clinic. Data were captured using Research Electronic Data Capture. Differences in frequency of patients who had been evaluated by DXA and/or prescribed antiosteoporotic therapy after hip fractures overall and stratified by sex and race were evaluated using Chi-squared tests. The study was approved by our hospital institutional review board. There were a total of 596 patients discharged with a primary diagnosis of hip fracture during the study period. After exclusions, 417 patients remained and were included in the analyses. The median age was 80yr (range: 65-95), 113 (27%) were men, and 243 were White women (57.9%). Overall, 10.3% of the patients were ordered DXA after their hospital discharge, 5.4% of men and 12.1% of women (p=0.05). A total of 19% received treatment for OP, and women were nearly 3 times more likely to receive treatment than men (23.2% vs 8%, p=0.004). The rates of DXA, treatment, and referral to rheumatology did not differ by race. The frequency of OP screening using DXA scan and the initiation of OP treatment was low in all patients after fragility fractures of hip. Women were more likely than men to receive DXA and significantly more likely to receive OP treatment. Although representative of only 1 hospital, these data suggest that more attention should be paid to possible OP among elderly patients hospitalized for hip fracture, and especially among men. Published by Elsevier Inc.

Entities:  

Keywords:  Hip fracture; osteoporosis; race; screening; sex

Mesh:

Substances:

Year:  2014        PMID: 24657109     DOI: 10.1016/j.jocd.2014.01.009

Source DB:  PubMed          Journal:  J Clin Densitom        ISSN: 1094-6950            Impact factor:   2.617


  20 in total

1.  UNDERSTANDING OSTEOPOROSIS SCREENING PRACTICES IN MEN: A NATIONWIDE PHYSICIAN SURVEY.

Authors:  Palak Choksi; Brittany L Gay; David Reyes-Gastelum; Megan R Haymart; Maria Papaleontiou
Journal:  Endocr Pract       Date:  2020-06-23       Impact factor: 3.443

2.  Older men who sustain a hip fracture experience greater declines in bone mineral density at the contralateral hip than non-fractured comparators.

Authors:  A M Rathbun; J Magaziner; M D Shardell; L M Yerges-Armstrong; D Orwig; G E Hicks; M C Hochberg
Journal:  Osteoporos Int       Date:  2017-10-24       Impact factor: 4.507

3.  Differences in geometric strength at the contralateral hip between men with hip fracture and non-fractured comparators.

Authors:  Alan M Rathbun; Jay Magaziner; Michelle D Shardell; Thomas J Beck; Laura M Yerges-Armstrong; Denise Orwig; Gregory E Hicks; Alice S Ryan; Marc C Hochberg
Journal:  Bone       Date:  2019-12-05       Impact factor: 4.398

4.  Effectiveness of resistance training or jumping-exercise to increase bone mineral density in men with low bone mass: A 12-month randomized, clinical trial.

Authors:  Pamela S Hinton; Peggy Nigh; John Thyfault
Journal:  Bone       Date:  2015-06-16       Impact factor: 4.398

Review 5.  Osteoporosis, bone mineral density and CKD-MBD: treatment considerations.

Authors:  Jordi Bover; Lucía Bailone; Víctor López-Báez; Silvia Benito; Paola Ciceri; Andrea Galassi; Mario Cozzolino
Journal:  J Nephrol       Date:  2017-04-21       Impact factor: 3.902

6.  Difference in the trajectory of change in bone geometry as measured by hip structural analysis in the narrow neck, intertrochanteric region, and femoral shaft between men and women following hip fracture.

Authors:  Alan M Rathbun; Michelle Shardell; Denise Orwig; J Richard Hebel; Gregory E Hicks; Thomas J Beck; Jay Magaziner; Marc C Hochberg
Journal:  Bone       Date:  2016-08-26       Impact factor: 4.398

7.  Disparities in osteoporosis treatments.

Authors:  Z Liu; J Weaver; A de Papp; Z Li; J Martin; K Allen; S Hui; E A Imel
Journal:  Osteoporos Int       Date:  2015-07-28       Impact factor: 4.507

8.  Differences in the trajectory of bone mineral density change measured at the total hip and femoral neck between men and women following hip fracture.

Authors:  Alan M Rathbun; Michelle Shardell; Denise Orwig; J Richard Hebel; Gregory E Hicks; Thomas Beck; Marc C Hochberg; Jay Magaziner
Journal:  Arch Osteoporos       Date:  2016-02-04       Impact factor: 2.617

9.  Low rates of osteoporosis treatment after hospitalization for hip fracture in Hawaii.

Authors:  E T Nguyen; T Posas-Mendoza; A M Siu; H J Ahn; S Y Choi; S Y Lim
Journal:  Osteoporos Int       Date:  2018-05-09       Impact factor: 4.507

10.  Understanding Osteoporosis Screening Practices in Men: A Nationwide Physician Survey.

Authors:  Palak Choksi; Brittany L Gay; David Reyes-Gastelum; Megan R Haymart; Maria Papaleontiou
Journal:  Endocr Pract       Date:  2020-06-23       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.